Houston Methodist Sugar Land Hospital Is First in Fort Bend to Use New Angioplasty System


Imran Mohiuddin, M.D. and patient Lorraine Morton.

Imran Mohiuddin, M.D. and patient Lorraine Morton.

Houston Methodist Sugar Land Hospital is the first in Fort Bend County to treat peripheral arterial disease (PAD) using a new drug-coated balloon catheter during angioplasty, a surgery to restore blood flow through an artery in the heart. Vascular Surgeon Imran Mohiuddin, M.D., performed the procedure in early November 2014 on a patient in Houston Methodist Sugar Land Hospital’s state-of-the-art cardiac catheterization lab.

PAD is a life-threatening condition that affects millions of Americans. Narrowed arteries can reduce blood flow to the extremities and create a number of serious medical conditions, including the need for limb amputation. Traditionally, PAD has been treated by inserting a catheter into the artery and inflating a small, balloon-like device to compress the buildup of plaque on the arterial wall and widen the artery.

The new Lutonix® system takes that process one step further, with a balloon that is pre-treated with the drug paclitaxel, which is typically used in chemotherapy to prevent cell growth. When the balloon is inflated within the artery at the site of the narrowing, paclitaxel is transferred to arterial walls, where it reduces the amount of scar tissue at the site.

“The combination of plaque compression and paclitaxel enables physicians to treat the initial blockage, as well as help prevent the recurrence of stenosis, or the narrowing of arteries,” said Dr. Mohiuddin. “Re-stenosis is a common problem with traditional percutaneous transluminal angioplasty. But the Lutonix system makes it possible to keep the treated artery open and allow sufficient blood flow for a longer period of time, reducing the risk of PAD in many patients.”

Studies show that the Lutonix drug-coated balloon improves patient blood flow by about 30 percent when compared with traditional balloon angioplasty. Approximately 90 percent of patients treated with the Lutonix system did not require further re-intervention within one year.

To schedule an appointment with Dr. Mohiuddin or another vascular surgeon on staff at Houston Methodist Sugar Land Hospital, call 281-274-7500. Visit www.houstonmethodist.org/sugarland or FB.com/methodistsugarland for more information, for the latest news, events and information.